Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Chi-Med mulls independent China development of new drugs

19.02.2014 / Scripintelligence

The "standout performance" of its drug R&D division, led by Hutchison MediPharma, means that the group can now look at such independent activities for selected pipeline projects. "We will continue to negotiate more collaborations on our broader pipeline…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: